PMC:7243778 / 38363-38998 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"981","span":{"begin":397,"end":402},"obj":"Species"},{"id":"982","span":{"begin":466,"end":471},"obj":"Species"},{"id":"983","span":{"begin":496,"end":501},"obj":"Species"}],"attributes":[{"id":"A981","pred":"tao:has_database_id","subj":"981","obj":"Tax:1570291"},{"id":"A982","pred":"tao:has_database_id","subj":"982","obj":"Tax:1570291"},{"id":"A983","pred":"tao:has_database_id","subj":"983","obj":"Tax:1570291"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Vaccine development is a long and expensive process. From identifying a virus to producing vaccines to market, it takes us a few years. If pandemic gets end before vaccines are approved, the research of vaccine candidates under development need to be continued and ready for clinical trials, in order to get emergency authorization when an outbreak recurs. This statement draws on experience from Ebola pandemic in which vaccine was still under development when the Ebola outbreak ended in 2016. Ebola vaccine is recently approved [[122], [123], [124]] and already used in the recent outbreak in the Democratic Republic of Congo [125]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T199","span":{"begin":397,"end":402},"obj":"Disease"},{"id":"T200","span":{"begin":466,"end":471},"obj":"Disease"},{"id":"T201","span":{"begin":496,"end":501},"obj":"Disease"}],"attributes":[{"id":"A199","pred":"mondo_id","subj":"T199","obj":"http://purl.obolibrary.org/obo/MONDO_0005737"},{"id":"A200","pred":"mondo_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/MONDO_0005737"},{"id":"A201","pred":"mondo_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/MONDO_0005737"}],"text":"Vaccine development is a long and expensive process. From identifying a virus to producing vaccines to market, it takes us a few years. If pandemic gets end before vaccines are approved, the research of vaccine candidates under development need to be continued and ready for clinical trials, in order to get emergency authorization when an outbreak recurs. This statement draws on experience from Ebola pandemic in which vaccine was still under development when the Ebola outbreak ended in 2016. Ebola vaccine is recently approved [[122], [123], [124]] and already used in the recent outbreak in the Democratic Republic of Congo [125]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T436","span":{"begin":23,"end":24},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T437","span":{"begin":70,"end":71},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T438","span":{"begin":72,"end":77},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T439","span":{"begin":123,"end":124},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Vaccine development is a long and expensive process. From identifying a virus to producing vaccines to market, it takes us a few years. If pandemic gets end before vaccines are approved, the research of vaccine candidates under development need to be continued and ready for clinical trials, in order to get emergency authorization when an outbreak recurs. This statement draws on experience from Ebola pandemic in which vaccine was still under development when the Ebola outbreak ended in 2016. Ebola vaccine is recently approved [[122], [123], [124]] and already used in the recent outbreak in the Democratic Republic of Congo [125]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T298","span":{"begin":0,"end":52},"obj":"Sentence"},{"id":"T299","span":{"begin":53,"end":135},"obj":"Sentence"},{"id":"T300","span":{"begin":136,"end":356},"obj":"Sentence"},{"id":"T301","span":{"begin":357,"end":495},"obj":"Sentence"},{"id":"T302","span":{"begin":496,"end":635},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vaccine development is a long and expensive process. From identifying a virus to producing vaccines to market, it takes us a few years. If pandemic gets end before vaccines are approved, the research of vaccine candidates under development need to be continued and ready for clinical trials, in order to get emergency authorization when an outbreak recurs. This statement draws on experience from Ebola pandemic in which vaccine was still under development when the Ebola outbreak ended in 2016. Ebola vaccine is recently approved [[122], [123], [124]] and already used in the recent outbreak in the Democratic Republic of Congo [125]."}

{"project":"2_test","denotations":[{"id":"32450171-28017403-66454518","span":{"begin":533,"end":536},"obj":"28017403"},{"id":"32450171-30685246-66454519","span":{"begin":540,"end":543},"obj":"30685246"},{"id":"32450171-27686015-66454520","span":{"begin":547,"end":550},"obj":"27686015"},{"id":"32450171-31141654-66454521","span":{"begin":630,"end":633},"obj":"31141654"}],"text":"Vaccine development is a long and expensive process. From identifying a virus to producing vaccines to market, it takes us a few years. If pandemic gets end before vaccines are approved, the research of vaccine candidates under development need to be continued and ready for clinical trials, in order to get emergency authorization when an outbreak recurs. This statement draws on experience from Ebola pandemic in which vaccine was still under development when the Ebola outbreak ended in 2016. Ebola vaccine is recently approved [[122], [123], [124]] and already used in the recent outbreak in the Democratic Republic of Congo [125]."}